Emergent BioSolutions is up 17.5%, or $1.56 to $10.46.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EBS:
- U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
- Emergent BioSolutions falls -10.3%
- Emergent BioSolutions falls -11.5%
- Emergent BioSolutions downgraded to Underweight from Neutral at JPMorgan
- Emergent Bio Up as Street Biggies Lap Up Shares